Epidemiological studies have reported a higher incidence of growth disorders among newborns conceived by in vitro fertilization (IVF), suggesting that IVF may be disruptive to the process of embryonic and fetal growth. However, the long-term effects of IVF on the growth and molecular mechanisms remain unclear. Therefore, we evaluated the body weight of IVF mice from birth to the age of 1.5 yr. In addition, we analyzed gene expression of insulin-like growth factor 2 (Igf2), H19, Igf2 receptor (Igf2r), and miR-483 and their DNA methylation status using real-time quantitative PCR, Western blot, and pyrosequencing. The results showed that when compared with the in vivo group, the body weight of IVF mice was significantly higher at birth, but lower at 3 wk; in addition, gene expression of Igf2 was significantly up-regulated, with down-regulated expression of H19 and miR-483 in both liver and skeletal muscle. At the same time, there were significant differences in the DNA methylation rates of Igf2/H19 differentially methylated regions (DMRs) and the IGF2 protein expression between the two groups. In the IVF treatment group, the differences in growth and expression disappeared at 10 wk. However, at 1.5 yr of age, aberrant expressions of Igf2/H19, Igf2r, and miR-483 and changes in DNA methylation rates in the liver or skeletal muscle were again observed in IVF mice. Our results indicate that IVF causes alterations in mouse growth during the postnatal periods that may be associated with alterations in Igf2/H19 expression and likely involve the regulation of miR-483 and the methylation status of Igf2/H19 DMRs.
INTRODUCTION
Since the birth of Louise Brown in 1978, in vitro fertilization and embryo transfer (IVF-ET) has proven to be a highly successful method for the treatment of infertility. To date, more than 4 million children have been conceived and born through IVF or its derivative techniques all over the world [1] . However, the safety of IVF with respect to the offspring continues to remain unknown [1] . In addition to the slight increased risk of congenital malformations, neurodevelopmental delays, and imprinting disorders, there is a 2-4-fold higher incidence of low birth weight (LBW) when compared with naturally conceived newborns, thus representing yet another abnormality in IVF offspring [2] [3] [4] . Although the multiple pregnancies and premature delivery associated with IVF-ET could partially explain this in most cases [5] , the exact mechanisms underlying this are not clearly understood.
In vitro studies have shown that exposure to insulin-like growth factor 2 (IGF2) profoundly affects tissue and cell growth, differentiation, and fetal development [6] . It is well known that most organs and tissues can produce IGF2; however, the liver is the most important synthesis center for circulating IGF2, and muscle is the predominant tissue for IGF2 production and targeting [7] . In pigs, one variant in an IGF2 intron was associated with a 3-fold greater abundance of Igf2 mRNA in muscle and a 3%-4% increase in total muscle mass [8] . Igf2 and H19 are two closely linked genes that are found on chromosome 7 in mice and expressed in the same tissues during development, albeit from differing parental alleles [9] . In addition, the literature has demonstrated that the IGF2 receptor (IGF2R) plays an important role in IGF2 signaling. Ablation of Igf2r leads to elevated circulating levels of IGF2, enlarged placentas, and overproliferation of cells [10] . Although the association between abnormal weight and changes in the level of serum IGF2 in IVF infants has been reported [11, 12] , the expression and regulation of Igf2/H19 and Igf2r in IGF synthesis centers and target organs, i.e., liver and muscle, have not yet been researched in IVF offspring.
It is commonly accepted that the epigenetic mechanisms of DNA methylation modification and microRNA (miRNA) regulation are important in gene expression regulation [13] . The methylation of DNA at cytosine residues of CpG dinucleotides in the differentially methylated regions (DMRs) is an important epigenetic regulatory mechanism for gene imprinting. Igf2/H19 and Igf2r are imprinted genes with parental allele-specific methylated regions. These genes are fully methylated on maternal alleles (Igf2r and H19) or paternal alleles (Igf2) in somatic cells. Four DMRs regulate Igf2/H19 expression in mice, including the Igf2 DMRs (DMR0, DMR1, and DMR2) and H19 DMR [14] [15] [16] . Of these DMRs, Igf2 DMR2 and H19 DMR have been identified as methylationsensitive activators. Studies of transgenic mice bearing DMR2-deleted Igf2r have revealed that the region is essential for maternal allele-specific expression of the gene [17] . It has been previously demonstrated that IVF disturbs DNA methylation patterns at specific locations of the Igf2/H19 locus in mouse embryos [18] [19] [20] . Recently, a well-designed study evaluated the effects of ovulation, fertilization, embryo culture, and type of culture media on the methylation status of H19 DMR in mouse embryos and suggested that H19 could be used as a sensor of the epigenetic disturbance of the utilized techniques [21] . In human, early-life environmental conditions also can cause epigenetic changes that persist throughout life [22] . Disrupted DNA methylation of Igf2/H19 DMRs and Igf2r DMR has been proposed in oocyte, placenta, or neonatal blood from in vitro culture or IVF [23] [24] [25] . miR-483, a miRNA coding for the second intron of Igf2, was recently found to be a regulatory factor for Igf2/H19 expression [26] . Research suggests that miR-483 may influence metabolism and growth by regulating its host gene Igf2 [27, 28] . Thus, further research on changes in the methylation of Igf2/H19 DMRs, Igf2r DMR, and the expression of miR-483 in IVF offspring from birth to old age is needed.
The data have already demonstrated that events during early development have a profound impact on one's risk for the development of some diseases in adulthood. LBW or being disproportionately large at birth, which can be induced by periconceptional exposure, is linked to coronary artery disease, hypertension, obesity, and insulin resistance [29] . Recently, two reports have shown that IVF offspring exhibit a higher incidence of LBW but a significantly larger gain in weight and height during the periods from birth to 18 yr old [30, 31] . Thus, these data raise new questions concerning the possible association of IVF with adult diseases. In this study, we use a mouse model to explore the growth alterations noted in IVF offspring throughout development, their associations with the expression of Igf2/H19 and Igf2r, and the epigenetic regulatory mechanisms involved in the changes in liver and skeletal muscle as IVF-derived mice age.
MATERIALS AND METHODS

Experimental Animals
C57BL/6J female (6-8 wk old) and male mice (10-12 wk old) were used in this study. All animals were housed with a 12L:12D cycle at 25 6 0.58C and at 50%-60% humidity. Mice were fed using a standard pellet diet and water. All treatment protocols involving the use of animals were approved by the Zhejiang University Animal Care Committee according to the Institutional Guidelines for Animal Experiments (No. ZJU2009101007Y). The C57BL/6J female mice were randomly divided into an IVF group and an in vivo group.
Production of IVF Mice and In Vivo Mice
Superovulation in C57BL/6J female mice was induced intraperitoneally by first administering 7.5 IU of equine chorionic gonadotropin (Gen's) and 7.5 IU of human chorionic gonadotropin (hCG) (Gen's) 48 h later. Human tubal fluid (HTF) (Irvin Scientific) medium containing 10% synthetic serum substitute (Irvin Scientific) was equilibrated at 378C in 5% CO 2 in air overnight before use.
For the IVF group, C57BL/6J female mice were killed using cervical dislocation 15 h after the administration of hCG, and the oviducts were surgically isolated and placed in warmed G-MOPS (Irvin Scientific). Metaphase II (MII) stage oocytes, which were identified by the presence of the first polar body, were isolated from oviducts. The epididymis was surgically isolated from C57BL/6J male mice and placed in warmed G-MOPS. After transferring to freshly warmed HTF, pressure was applied to the tissue to cause the sperm to exit and the sperm was then incubated in 5% CO 2 at 378C for 1.5 h to allow for capacitation. The capacitated sperm was added to the HTF medium with 10-15 MII oocytes in a final sperm concentration of 1-2.5 3 10 6 ml À1 . Six hours later, the presumptive embryos were gently washed twice and cultured in fresh HTF in 5% CO 2 at 378C. The 2-cell stage embryos of the IVF group were obtained 24 h later.
For the in vivo group, after administering of hCG, C57BL/6J female mice were caged with male mice at a ratio of 1:1. The following day, female mice with a vaginal plug were separated from the males. Forty-four hours later, the 2-cell embryos of the in vivo group were obtained from the oviducts. The culture conditions were the same as in the IVF group.
Embryo Transfer
Institute of Cancer Research (ICR) female mice that were at least 8 wk of age were used as pseudopregnant recipients. Vaginal plugs were detected the morning after mating with ICR vasectomized males, which was considered Day 0.5 of pseudopregnancy. Twelve to 15 morphologically normal embryos at the 2-cell stage in each group were transferred into the oviducts of a 0.5-day pseudopregnant foster mother. All pregnant recipients were allowed to proceed to term and to give birth to live offspring for analysis and subsequent breeding.
Postnatal Growth
For the purpose of weight measurement, the mice were weighed weekly from birth to the age of 10 wk and biweekly from the age of 11 wk to 1.5 yr. At birth, 3 wk (weaning), 10 wk (adult), and 1.5 yr (old age), the mice were killed, and the skeletal muscle (from the quadriceps femoris), liver, lung, heart, kidney, pancreas, spleen, brain, and testis were excised and weighed. The tissues were frozen separately in liquid nitrogen just after collection and stored at À808C for further RNA and DNA extraction.
RNA Extraction and Reverse Transcription
Using the RNAiso Plus kit (TaKaRa), total RNA was isolated from liver and skeletal muscle (n ¼ 10/group, 5 females and 5 males) according to the manufacturer's instructions at all the time points. The RNA was first treated with DNase (TaKaRa) in a 10-ll reaction with 5 3 genomic DNA (gDNA) Eraser Buffer (2 ll; TakaRa), gDNA Eraser (1 ll; TakaRa), and total RNA (1 lg). The reaction was conducted at 428C for 2 min.
For the mRNAs (Igf2, H19, Igf2r, and Gapdh), the PrimeScript RT Reagent Kit (TaKaRa) was used for reverse transcription (RT) in a total volume of 20 ll with 4 ll 53 PrimeScript Buffer PCR buffer, 1 ll PrimeScript RT enzyme mix I, 1 ll RT primer mix, and 10 ll of the above RNA sample. The RT reaction started with a 15-min incubation period at 378C, and ended after a 5-sec enzyme denaturing step at 858C.
For the miRNAs (miR-483 and U6 small nuclear RNA [snRNA]), RT was performed in a total volume of 20 ll with 4 ll 53 RT buffer, 0.75 ll dNTP (10 mM), 1.2 ll MIR-RT primers or U6 snRNA RT primers (1 lM), 0.2 ll MMLV reverse transcriptase (200 U/ll) (GenePharma), and 10 ll RNA sample after DNase treatment. The reaction was performed at 168C for 30 min, followed by 428C for 30 min and finally 858C for 10 min.
Real-Time Quantitative PCR
Real-time amplification of Igf2, H19, Igf2r, Gapdh, miR-483, and U6 snRNA was performed using the SYBR Premix Ex Taq (TaKaRa) in an ABI 7900 thermocycler (Applied Biosystems). Primers TGTTGACACGCTT-CAGTTTGTCTG and GAAGCAGCACTCTTCCACGATG (predicted size, 106 nucleotides [nt]) were used for Igf2; primers GCACTAAGTCGATTG-CACTGG and GCCTCAAGCACACGGCCACA (predicted size, 163 nt) were used for H19; primers GATCCCAGAGTTCAGCCACGA and CCTGCGCTCTCATCCTCAAAG (predicted size, 105 nt) were used for Igf2r; and primers TGTGTCCGTCGTGGATCTGA and TTGCTGTTGAAGTCG-CAGGAG (predicted size, 150 nt) were used for Gapdh. Real-time PCR was carried out in a 10-ll reaction system containing 5 ll SYBR Premix Ex Taq (23), 0.4 ll PCR primers (10 lM), 0.2 ll ROX reference dye, and 1 ll cDNA or miRNA sample (100 ng). PCR thermal cycling parameters were 958C for 10 sec, followed by 40 cycles of 958C for 5 sec, and then 608C for 30 sec. After PCR, a dissociation curve was constructed at 958C for 15 sec, 608C for 15 sec, and 958C for 15 sec for detection of PCR product specificity. Each reaction was performed in triplicate. The reference genes Gapdh and U6 snRNA were used as relative controls for the expression levels of Igf2/H19 or Igf2r and miR-483, respectively. The change was calculated using the comparative cycles to threshold (Ct) method. The calculation of gene expression was made as follows using the comparative hepatic Igf2 expression of the IVF group as an example:
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DNA for Methylation Analysis
Extracting genomic DNA. DNA was isolated from liver and skeletal muscle (n ¼ 10/group, 5 females and 5 males) using proteinase K digestion followed by phenol-chloroform extraction and ethanol precipitation (Sangon Biotech) at all the time points, and then bisulfite modification was used immediately or stored at À208C for later use.
Genome bisulfite modification. DNA (1 lg) was processed for bisulfite sequencing analysis using the EpiTect Bisulfite kit (Qiagen) following the manufacturer's protocol. The bisulfite reaction was performed using the Bisulfite Mix and DNA protect buffer. After the reactants were mixed, the program was carried out as follows: 958C 5 min; 608C 25 min, 958C 5 min; 608C 85 min; 958C 5 min; 608C 175 min; and 208C indefinite (valid overnight). The bisulfite-converted DNA was immediately used for the PCR reaction.
Methylation-specific PCR (MSP). The MethPrimer software [32] was used to identify CpG islands and to design primers for the H19 DMR (C57BL no. AY849916, Cast no. AY849917), Igf2 DMR2 (C57BL no. AY849922, Cast no. AY849923) and Igf2r DMR2 (GenBank accession number L06446) [33] . The primers used were as follows: H19 DMR (211 nt), forward primer (F) 5 0 -TTTTTGGGTAGTTTTTTTAGTTTTG-3 0 and reverse primer (R)-
0 and R 5 0 -TTAAGGGTGAAAAG TTGTATAAGGAG-3 0 . Methylation-specific PCR was carried out in a 50-ll reaction containing 5 ll 103 Taq buffer, 4 ll dNTP (2.5 mM), 2 ll PCR primers (20 lM), 0.3 ll Taq Ex HotStart (5 U/ll) (TaKaRa), and 2 ll DNA (150 ng). Bisulfite-converted DNA amplification was conducted using a PCR program; the protocol for this was as follows: predenaturation at 948C for 5 min, followed by 20 cycles of 948C for 30 sec, 60-508C (decrease 0.58C in each cycle) for 45 sec, and 728C for 45 sec; then 30 cycles of 948C for 30 sec, 508C for 45 sec, and 728C for 45 sec; and finally 728C for 10 min.
Pyrosequencing analysis.The PSQ Assay Design software was used for designing sequencing primers for the H19 DMR, Igf2 DMR2, and Igf2r DMR2. The sequencing primers used were as follows: H19 DMR (three CpG sites), 5 0 -TTGTGTAGATTTGGTTATAG-3 0 ; Igf2 DMR2 (five CpG sites), 5 0 -TGGAATTTTTAGGTAGGTTT-3 0 ; Igf2r DMR2 (four CpG sites), 5 0 -ACTCAACACAACCAAAAA-3 0 . After verification by standard gel electrophoresis on a 1.5% agarose gel, 45 ll of PCR product was incubated for 10 min at room temperature with shaking in the presence of 43 ll of binding buffer (10 mM Tris, 2 M NaCl, 1 mM EDTA, 0.1% Tween 20; pH 7.6; adjusted with 1 M HCl) and 2 ll of streptavidin-coated Sepharose beads (GE Healthcare). The binding mix was purified and rendered single stranded using the Pyrosequencing Vacuum Prep Workstation (Pyrosequencing AB) according to the manufacturer's instructions. The beads were released into 48 ll annealing buffer (20 mM Tris, 2 mM magnesium acetate tetrahydrate; pH 7.6; adjusted with 4 M acetic acid) containing 2 ll of the respective sequencing primer. The primers were annealed to the target by incubation at 808C for 2 min. Quantitative DNA methylation analysis was carried out on a PSQ 96 ID system with the PyroMark Gold Q96 Reagent Kit (Qiagen). The methylation analysis was performed in duplicate.
Western Blotting Analysis
Western blotting analysis was performed as described previously [34] . Briefly, the samples (liver and skeletal muscle) were homogenized in in 13 RIPA buffer (Solarbio). The protein concentration in the supernate was determined by Bradford assay (Bio-Rad Laboratories). Fifty micrograms of sample/lane were separated on a 12% SDS-polyacrylamide gel. The separated samples were transferred to nitrocellulose membranes and exposed to rabbit anti-IGF-II antibody (1:200 dilution; product no. SC-5622; Santa Cruz) and rabbit anti-actin antibody (1:1000; product no. 4970; Cell Signaling Technology, Inc.) for 2 h followed by incubation with DyLight 680-Labeled goat anti-rabbit IgG (H-L) (1:5000; product no. 072-06-15-06; KPL) for 1 h at room temperature and visualized with Odyssey Imager (LI-COR).
Data Analysis
All computations were performed using SPSS (version 16.0 for Windows; SPSS). Comparisons between the two groups were made using unrelated t-tests and a chi-square test. The data are presented as the mean 6 SD. In all cases, a value of P , 0.05 was considered significant.
RESULTS
Birth Outcome
A total of 51 IVF and 51 in vivo mice were delivered. There were no statistically significant differences between the IVF and in vivo groups in the gestation or litter size (Table 1 ). In addition, there were no statistically significant differences found in the birth:death ratio, sex ratio, or pregnancy rate between the two groups.
Body and Organ Weights
The body weights of the two groups are presented in Table  2 . At birth, the body weight of IVF mice was significantly higher than that of in vivo mice (1.53 6 0.15 g vs. 1.45 6 0.19 g, P , 0.05). However, after birth, the growth of IVF mice seemed to be much slower than that of in vivo mice. The body weight of IVF mice was significantly lower than that of in vivo mice at 3 wk (10.68 6 1.09 g vs. 11.33 6 0.78 g, P , 0.01). After 3 wk of age, the difference in body weight between the two groups disappeared.
There were no significant differences in the weight of organs, including the liver, kidney, pancreas, heart, and brain, at all the time points between the two groups ( Table 2) . 
LONG-TERM GROWTH ALTERATIONS IN IVF MICE
However, the weight of the spleen in IVF mice was significantly lower than that of in vivo mice at 10 wk (0.07 6 0.01 g vs. 0.10 6 0.03 g, P , 0.05).
Expression levels of Igf2 mRNA, H19 RNA, and Igf2r mRNA At birth and 3 wk of age, in the liver, as shown in Figure  1A , gene expression of Igf2 was significantly up-regulated (1.65-fold, P , 0.05, and 3.24-fold, P , 0.01, respectively) and gene expression of H19 was significantly down-regulated (0.82-fold, P , 0.05, and 0.65-fold, P , 0.01, respectively) in IVF mice compared with in vivo mice. At the age of 10 wk, the difference in gene expression of Igf2 and H19 between IVF and in vivo mice disappeared. However, when the mice reached the elderly age of 1.5 yr, gene expression of Igf2 (0.69-fold) and H19 (0.63-fold) in IVF mice was significantly lower (P , 0.01). Furthermore, there were no differences in the hepatic expression of Igf2r in IVF mice from birth to old age.
As shown in Figure 1B , in the skeletal muscle at 3 wk of age, gene expression of Igf2 was significantly up-regulated (1.80-fold, P , 0.01) and gene expression of H19 was significantly down-regulated (0.75-fold, P , 0.05) in IVF mice compared with in vivo mice. In addition, there were no significant differences in gene expression of Igf2 and H19 between IVF and in vivo mice at 10 wk of age. Gene expression of Igf2 (0.58-fold, P , 0.01) and Igf2r (0.69-fold, P , 0.01) became significantly lower in IVF mice with up-regulated expression of H19 (2.36-fold, P , 0.01) at old age. 
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Expression Level of miR-483 in the Liver and Skeletal Muscle
As shown in Figure 2A , down-regulation of hepatic miR-483 (0.75-fold, P , 0.05, and 0.58-fold, P , 0.01, respectively) was detected in IVF mice when compared with in vivo mice at birth and at 3 wk of age. In addition, gene expression of miR-483 was also lower in the skeletal muscle of IVF mice at 3 wk (0.54-fold, P , 0.01, Fig. 2B ). However, there were no significant differences in the expression of miR-483 at 10 wk in either the liver or skeletal muscle. When the mice reached 1.5 yr of age, the expression of miR-483 was significantly up-regulated in the liver and skeletal muscle of IVF mice (1.62-fold, P , 0.05, Fig. 2A , and 2.32-fold, P , 0.01, Fig. 2B, respectively) .
DNA Methylation Status of Igf2/H19 and Igf2r in the Liver
Given the disrupted hepatic expression of H19 and Igf2, the DNA methylation rate of the H19 DMR (CpG1-3 sites, Fig.  3A ) and the Igf2 DMR2 (CpG1-5 sites, Fig. 3B ) were chosen for further analysis using pyrosequencing. Moreover, four CpG sites on the Igf2r DMR2 (CpG1-4 sites, Fig. 3C ) were selected for methylation status analysis.
At birth, IVF mice showed significantly lower mean methylation rates than in vivo mice at all three CpG sites of H19 DMR (CpG1, 42.94% 6 0.97% vs. 49.00% 6 1.43%, P , 0.01; CpG2, 59.23% 6 1.53% vs. 65.58% 6 0.54%, P , 0.01; CpG3, 48.42% 6 2.51% vs. 51.74% 6 0.94%, P , 0.05; Fig. 4A ). As shown in Figure 4A , at 3 and 10 wk of age, there were no significant differences in the mean H19 DMR methylation observed between IVF and in vivo mice. In oldage mice, the mean H19 DMR methylation rate at the CpG3 site was significantly higher in IVF mice compared with in vivo mice (53.00% 6 1.25% vs. 51.12% 6 1.58%, P , 0.05, Fig. 4A ).
As shown in Figure 4B , there was a significantly lower mean methylation rate of Igf2 DMR2 at the CpG 4 site in IVF mice than in control mice at birth (41.34% 6 1.70% vs. 46.98% 6 3.85%, P , 0.05). At 3 wk of age, IVF mice exhibited significantly higher methylation rates of Igf2 DMR2 compared with in vivo mice at the CpG2 (30.88% 6 1.81% vs. 28.15% 6 1.14%, P , 0.01) and CpG4 sites (62.17% 6 16.59% vs. 47.99% 6 1.72%, P , 0.05). There was no significant difference in the mean Igf2 DMR2 methylation rate between the two groups at 10 wk of age. However, at old age (Fig. 4B ), higher methylation rates of Igf2 DMR2 were observed in IVF mice at the CpG1, CpG4, and CpG5 sites (43.13% 6 3.71% vs. 35.08% 6 1.73%, P , 0.01; 51.50% 6 2.35% vs. 48.87% 6 0.99%, P , 0.05; 52.73% 6 5.89% vs. 36.64% 6 1.01%, P , 0.01, respectively). Additionally, there was no difference in the mean methylation rate of Igf2r DMR2 between the two groups of mice from birth to old age (Fig. 4C) .
DNA Methylation Status of Igf2/H19 and Igf2r in the Skeletal Muscle
In skeletal muscle, as shown in Figure 5A , IVF mice at 3 wk of age showed significantly lower mean methylation rates of H19 DMR when compared with in vivo mice at all three CpG sites (CpG1, 57.88% 6 4.39% vs. 63.40% 6 2.37%; CpG2, 65.88% 6 4.36% vs. 72.80% 6 2.39%; CpG3, 56.75% 6 3.58% vs. 63.40% 6 2.01%; P , 0.01). There was no significant difference in H19 DMR between the two groups at 10 wk of age or old age.
At 3 wk of age, there were significantly lower mean methylation rates of Igf2 DMR2 in IVF mice when compared with in vivo mice at the CpG2 site (27.90% 6 1.45% vs. 29.25% 6 0.71%, P , 0.05, Fig. 5B ). As noted in Figure 5B , the difference in Igf2 DMR2 methylation rates among IVF mice disappeared at approximately 10 wk of age. However, at old age, higher mean methylation rates of Igf2 DMR2 were observed in IVF mice at the CpG2, CpG3, and CpG5 sites (29.00% 6 0.94% vs. 27.11% 6 1.76%, P , 0.01; 30.11% 6 1.62% vs. 28.33% 6 1.58%, P , 0.05; 28.22% 6 1.48% vs. 26.00% 6 2.06%, P , 0.05, respectively).
As shown in Figure 5C , the mean methylation rate of Igf2r DMR2 in the skeletal muscle of IVF mice was similar to that of in vivo mice at both 3 and 10 wk. However, at old age, the methylation rates of Igf2r DMR at four sites were significantly higher in IVF mice than in control mice (CpG1, 58.00% 6 2.91% vs. 52.29% 6 2.43%; CpG2, 44.80% 6 1.55% vs. 40.38% 6 1.85%; CpG3, 60.30% 6 2.63% vs. 52.88% 6 2.53%; CpG4, 60.70% 6 2.36% vs. 55.25% 6 2.71%, P , 0.01, respectively).
Expression Level of IGF2 Protein in the Liver and Skeletal Muscle
Based on the above expression results, it is clear that aberrant expression of Igf2 mRNA occurred in IVF mice from birth to old age. Thus, the expression of the IGF2 protein was analyzed at those stages. At 3 wk, in both the liver and skeletal muscle, the expression of IGF2 protein was significantly lower in IVF mice than in control mice (Fig. 6, A and B) . However, there was no statistically significant difference in IGF2 protein   FIG. 2 . Analysis of miR-483 expression levels in the IVF and in vivo groups by real-time quantitative PCR from birth to old age. A) Relative abundance expression of miR-483 in the liver at birth, 3 wk, 10 wk, and 1.5 yr. B) Relative abundance expression of miR-483 in the skeletal muscle at 3 wk, 10 wk, and 1.5 yr. Data concerning the relative miR-483 concentrations normalized to U6 snRNA; the relative levels were calculated using the 2
ÀDDCt method. Mean 6 SD values are plotted. *P , 0.05; **P , 0.01.
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expression between IVF and in vivo groups at other stages (Fig. 6, A and B) .
DISCUSSION
This study is the first to examine growth and regulatory mechanisms from birth to old age by using the liver and skeletal muscle tissues of IVF and in vivo mice. There was a significant change in the body weight of IVF mice in our study during the weaning stage. In addition, the expression analysis did indeed show that the transcription levels of Igf2 and H19 were differentially regulated in liver and skeletal muscle in both young and elderly IVF mice when compared with in vivo mice. Moreover, we found that the expression pattern of Igf2r in IVF mice was similar to that in control mice in the liver; however, the expression pattern was aberrant in the skeletal muscle of aged IVF mice. After further analysis using pyrosequencing, it was noted that IVF produced persistent changes in expression through epigenetic regulatory networks.
The majority of human studies have shown that the birth weight of IVF-conceived newborns is decreased when compared to those conceived naturally [2] [3] [4] . The reasons for the decreased birth weight noted in IVF newborns include the presence of multiple pregnancies, prematurity, and subfertility in women who undergo IVF [35, 36] . Although some reports have suggested that superovulation or embryo transfer is associated with aberrant development of postimplantation embryos [37, 38] , it is unclear whether the IVF procedure itself actually affects the development potential of the infant or child. In the present study, we used an in vivo mouse model that used the same protocols of ovarian stimulation, embryo culture, and embryo transfer as IVF and established this group as the control group. After comparing IVF and in vivo mice, we found that the IVF procedure increased the intrauterine growth of mice. This finding is consistent with the literature, which has shown increased body weight in the in vitro culture animals and evidence of significant changes in body weight or only slight increases in body weight in human newborns conceived via IVF [39] [40] [41] . However, mouse tends to be polyembryonic, whereas humans tend to carry a single pregnancy. The influence of species differences on the development of IVF offspring requires further exploration.
An aberrant postnatal growth rate in children conceived via IVF was reported by Lee et al. [30] and Ceelen et al. [31] , who found that children conceived via IVF showed a significantly greater gain in weight and height during late infancy compared with controls. This childhood growth pattern is also termed ''catch-up growth.'' In the present report, newborns conceived via IVF had relatively increased weight at birth and showed postnatal slow or ''catch-down'' growth. Previous data have highlighted the fact that early postnatal catch-up and catchdown growth patterns are closely related to unfavorable prenatal conditions during pregnancy [42, 43] . It seems that IVF mice must undergo a physiological compensatory process to promote the restoration of their intrauterine growth disruption during infancy. In humans, the two growth patterns are observed largely within the first year of life, although they may take up to 2 yr to resolve [44] . In our mice, after 3 wk, there were no longer differences in body weight between the IVF and control mice. However, both of the early postnatal growth patterns appear to be associated with long-term risks of various diseases in adulthood, including type 2 diabetes and cardiovascular disease [45, 46] . Thus, an understanding of early growth patterns and their associations with later cardiometabolic health and how these trends may subsequently be modified by the genetic background will be important in developing appropriate targeted interventions to prevent the risks of adulthood disease associated with assisted reproduction.
Gene knockout animal models have shown that the insulinlike growth factors, their receptors, and regulatory proteins have major effects on fetal growth and development [10, 16, 17] . Therefore, in this work, we analyzed gene expression of these growth-related imprinting genes. Under our experimental conditions, IVF mice showed a higher expression of Igf2 mRNA and significantly lower IGF2 protein levels in both liver and skeletal muscle and decreased body weight at 3 wk of age. There are many complicated and varied posttranscriptional LE ET AL. mechanisms involved in turning mRNA into protein that make it difficult to compute protein concentrations from mRNA [47] . In this work, a lower gene expression of H19, which acts as a miRNA precursor [48] , was detected at 3 wk. Furthermore, miR-483 was suspected as a posttranscriptional regulator of Igf2, and the lower expression of miR-483 was found in IVF mice at 3 wk, suggesting that the absence of an mRNA-protein correlation at 3 wk may be due to posttranscriptional miRNA regulation. Recently, several studies have suggested that ageassociated loss in muscle fibers may be related to the decline in local production of IGFs [49, 50] . Our findings also confirmed that Igf2 and H19 expression levels decrease dramatically in both the liver and skeletal muscle in concert with the decrease in growth velocity among IVF-conceived mice. Moreover, this study showed a correlation between miR-483 and Igf2 expression levels in the skeletal muscle and liver of elderly IVF mice. Based on the results presented here, our data strongly suggest that Igf2/H19 and miR-483 expression may be affected by IVF, which may contribute to alterations in the organism's development and proliferation.
Given the epigenetic modification of imprinted genes implicated in development and in an effort to determine whether differential methylation patterns were related to the above aberrant gene expression, we investigated the methylation status of those genes. To our knowledge, this is the first description of an altered methylation status of Igf2/H19 in the liver and skeletal muscle in response to an in vitro challenge. In the present work, IVF newborn mice showed hypomethylation of H19 DMR in accordance with the increased expression of Igf2 transcripts, suggesting that these genes may be particularly vulnerable to differential methylation because of early life manipulation. In addition, hypermethylation of Igf2 DMR2 was examined along with the higher expression of Igf2 mRNA at 3 wk. This result was consistent with the previous observations, which suggest that the methylated core DMR 2 is needed for high-level expression of Igf2 [51, 52] . Furthermore, disrupted DNA methylation of H19/Igf2 with aberrant mRNA expression has been observed in elderly mice, highlighting a specific epigenetic variability associated with aging. Young et al. [39] found a 30%-60% reduction in Igf2r mRNA in sheep with large organ syndrome that were conceived by IVF, and this difference was accompanied by the loss of methylation of the maternal Igf2r DMR. Although our results showed normal expression and epigenetic patterns of Igf2r in the liver, abnormal expression and methylation status were detected in the skeletal muscle of elderly IVF mice. This implies that the regulatory elements for Igf2r activity in the skeletal muscle are physically separated from those regulating its expression in the liver. Furthermore, our previous study has demonstrated that IVF may modify the somatic methylation pattern and that some of this aberrant methylation might be inherited by the subsequent generation [53] , suggesting that epigenetic effects on growth-related genes could extend beyond the F1 generation; however, further research concerning these effects is needed.
DNA methylation of the imprinted genes is erased in the primordial germ cells and reestablished later during gametogenesis to form functional gametes that can give rise to normal individuals after fertilization [54] . We identified IVF-conceived mice that showed both paternal (H19 DMR and Igf2r DMR2) and maternal (Igf2 DMR2) methylation errors in the liver or skeletal muscle. This could suggest a more wideranging defect in establishing or maintaining appropriate methylation of Igf2/H19 in the embryonic cleavage or early conceptus. Recent data suggest that the increase in the incidence of imprinting disorders in individuals born by assisted reproductive technologies (ART) may be due to the use of sperm with intrinsic imprinting mutations and not a consequence of the ART [55] [56] [57] . In our studies, we found that the epigenetic disturbance in mice was caused by the IVF process. However, the risks cannot easily be evaluated for ART treatment because patients who receive ART treatment may differ both demographically and genetically from the mice. Thus, as technology and understanding continues to improve, researchers will continue to uncover the intricate effects of ART on development.
In summary, our study showed alterations in the weight of newborns as well as long-lasting changes in Igf2/H19 in both liver and skeletal muscle of mice conceived by IVF. Moreover, the aberrant growth that was noted along with Igf2/H19 differences in IVF offspring may be associated with epigenetic mechanisms such as DNA methylation and miR-483. Given the wide use of assisted reproductive technologies, it will be important to continue investigating the exact mechanisms by which environmental factors influence the epigenome. Further, this study demonstrates the need to monitor the health of IVF offspring throughout childhood into old age.
